Amarin Corp Plc (AMRN)

[Biobillionair]

Addition of the Anchor data to the label was an agreement made with Marine approval. REDUCEIT was required to 50% enrolled...I'll see if I can find the document. As far as adding the JELIS study, that's news to me but would fall inline with the new Guidance document posted at the FDA.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf

I posted this before but got no takers at the time. Vascepa would qualify under this guidance for early REDUCEIT approval before the outcome study is fininshed. It was posted 6-25.

Will